Breaking News

Has no content to show!

Pharmaceutical News

Sun Pharma posts Q1 loss at Rs 425 cr on settlement provision; US biz drags revenue 25%

Sun Pharmaceutical Industries' first quarter earnings disappointed analysts on Friday as it posted consolidated loss of Rs 425 crore due to provision for settlement with certain plantiffs.


Dr. Reddy’s US drug products pipeline lucrative but hurdles are aplenty

Dr. Reddy’s Laboratories Ltd has one of the strongest product pipelines for the US market among Indian generic drug makers but high risks involved in monetizing this pipeline have kept investors at bay.


Dr.Reddy's First-Quarter Profit Slumps 57%

Dr. Reddy's Laboratories Ltd said its first-quarter profit more than halved from a year ago, as regulatory hurdles and pricing pressures in its biggest market, the United States, dragged on the drugmaker's earnings.


Lupin spends big on quality control as US FDA ups scrutiny on Indian pharma

 In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier.Most of the last six months on his desk calendar is marked green, indicating visits to the 12 plants of Lupin, India's No. 2 drugmaker, where Desai is a senior quality control executive. Only one day is red - a day off.


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners